Aids experts unravel key secret of HIV
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.In a burst of research that could lead to new Aids treatments, scientists have identified one and possibly three chemical footholds that HIV - the virus that causes the disease - needs to infect a person's cells.
Unlike a similar discovery announced last month, the new work involves strains of the virus, commonly spread from person to person.
Altogether, the discoveries are important because they are "telling us very basic things about what HIV needs to infect cells", said Dr James Hoxie, a researcher at the University of Pennsylvania who was not involved with the reported studies. "This is the first real hard insight into a process that's been very elusive until now."
Scientists have long known that to get inside cells, HIV attaches itself to a structure on the cell surface called CD4. But it has also been clear that HIV needed another foothold as well.
Last month, researchers reported that for some strains of HIV, this second foothold is a cell protein called fusin.
But fusin does not appear to be used by HIV strains that are most commonly transmitted between people and which predominate early in the course of a person's infection.
Now, five teams of scientists say they have identified a foothold for these strains.
It is a protein found on blood cells, and it normally acts as a docking site for chemokines. Chemokines are chemical messages that summon blood cells to the sites of inflammation.
Chemokines made headlines last year when research showed they could virtually stop HIV from reproducing in the test-tube.
The new work shows that chemokines keep HIV from even entering blood cells, a necessary step for HIV reproduction.
"They pretty much shut the door on the virus getting in," said one of the researchers, Dr Dan Littman, of the Howard Hughes Medical Institute at the New York University Medical Center.
Chemokines may shut the door by blocking HIV's access to their docking sites, called receptors, researchers said. So designing drugs to do the same thing may provide a new route of therapy.
The chemokine receptor implicated by the five scientific teams is called CC-CKR-5.
The research appears in the latest issue of the journal Nature and the 28 June editions of the journals Science and Cell.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments